middle.news
ReNerve Taps J4 to Boost Empliq Production Amid Rising Hospital Demand
9:47am on Thursday 11th of June, 2026 AEST
•
Healthcare
Read Story
ReNerve Taps J4 to Boost Empliq Production Amid Rising Hospital Demand
9:47am on Thursday 11th of June, 2026 AEST
Key Points
J4 Biologics appointed as second Empliq manufacturer
Dual-supplier strategy to improve supply chain resilience
Minimum purchase commitments set with flexible scaling
Empliq benefits from recent hospital approvals
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Renerve (ASX:RNV)
OPEN ARTICLE